TD Cowen is analyzing the stock performance of Nasdaq, Inc., a company operating in the US and internationally.
1 report, 1 independent
Updated Jul 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen is analyzing the stock performance of Nasdaq, Inc., a company operating in the US and internationally.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq, Inc.
American multinational financial technology services corporation
-
TD Cowen
American investment bank
Related events
- TD Cowen issued a buy rating and price target for Evolv Technologies Holdings, Inc.
- Nasdaq survey gathered insights across seven countries.
- EyePoint Pharmaceuticals was listed on Nasdaq, accompanied by rating updates from TD Cowen (downgrade) and Jefferies (upgrade).
- TD Cowen and Royal Bank of Canada published research reports on ChargePoint shares.
- TD Cowen is managing a share offering for PMV Pharma, which has been filed with the SEC and utilizes Broadridge Financial Solutions for mailing the prospectus.